Ligamentum Teres Tenodesis in Developmental Dysplasia of the Hip

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-21

Study Completion Date

2023-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The treatment of developmental dysplasia of the hip (DDH) remains challenging, yet recent advances have refined our understanding of how best to survey for the condition during infancy, minimize complications during early treatment, and refine the selection of patients who can best benefit from hip preservation surgery. The ideal continued target would be to prevent missed hip dislocations or dysplasia during the infant period, prevent avascular necrosis (AVN) during early treatment, and decrease the incidence of total hip arthroplasty in adulthood related to undertreated DDH, The goal of the treatment is to achieve a concentric reduction of the femoral head into the acetabulum.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Modified Hip Capsular Incision: an Easier Way to do Hip Capsulorrhaphy in Developmental Dysplasia of the Hip (DDH)

NCT05717829

Developmental Hip Dysplasia

UNKNOWN NA

Does a 6-week Duration of Hip Spica Immobilization Provide Comparable Clinical and Radiological Outcomes to 12 Weeks in Children Undergoing Open Reduction and Pelvic Osteotomy for Developmental Dysplasia of the Hip (DDH)?

NCT07289256

DDH

NOT_YET_RECRUITING NA

Surgical Treatment of DDH With and Without Capsulorrhaphy

NCT06442722

Developmental Dysplasia of the Hip

NOT_YET_RECRUITING NA

Comparison Between Two Techniques of Capsulotomy During Capsulorrhaphy in Cases of Developmental Dysplasia of the Hip

NCT06439147

Developmental Dysplasia of the Hip

ENROLLING_BY_INVITATION NA

Developmental Dysplasia of the Hip: Observation vs. Bracing

NCT05869851

Developmental Dysplasia of the Hip Hip Dysplasia Hip Dysplasia, Congenital +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

it is an operative technique to secure the femoral head after reduction in cases of developmental dysplasia of the hip

Operative technique:

The surgery will be accomplished under a general anesthesia.

An addition to the steps of the open reduction, the following were done:

1. Identification of ligamentum teres
2. ligamentum teres tenodesis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthopedic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ligamentum teres tenodesis

Identification of ligamentum teres ligamentum teres tenodesis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with Developmental dysplasia of the hip (DDH) with :

* Age: from 9 months -5 years old.
* Virgin DDH.
* Failed closed reduction in the management of DDH.
* Failed open reduction through medial approach in the management of DDH

Exclusion Criteria

* • Paralytic hip dislocation .

* Post septic hip dislocation.
* Traumatic hip dislocation .
* Age : below 9 months or above 5 years.
* Refusal to participate in this study.

Minimum Eligible Age

9 Months

Maximum Eligible Age

60 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No